AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Veradigm Inc.
Video analysis: MDRX
All videosNo video analysis for this stock yet. Request one from our team.
News: MDRX
Veradigm (NASDAQ:MDRX) & Augmedix (OTCMKTS:AUGX) Financial Comparison
Insider and Institutional Ownership 87.1% of Augmedix shares are held by institutional investors. 2.3% of Veradigm shares are held by company insiders. Comparatively, 11.0% of Augmedix shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the
Veradigm to Participate in Two Upcoming Investor Conferences
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management will be participating in the following investor conferences in September. 2026 Jefferies Healthcare Services and Technology Conference (Nashville, September 15, 2026) Don Trigg, Chief Executive Officer, and Christian Greyenbuhl, Chief Financial Officer, will hold one-on-one meetings and participate in a fireside chat on Tuesda.